Work

Feasibility and Safety of IL-15-Activated CD56+ Cell Therapy in High-Risk Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation: Phase I Clinical Trial.

Year: 2026

Type: article

Study design: Clinical Trial

Source: PubMed

DOI: 10.22074/cellj.2025.2057631.1827

Authors: Shiva Eskandarian, Amirhossein Izadpanah, Mozhdeh Mohammadian, Mehdi Bakhtiyaridovvmbaygi, Mehrshad Seresht-Ahmadi, Sahar Parkhideh, Elham Roshandel, Ahmad Gharehbaghian, Abbas Hajifathali

Institutions: Shahid Beheshti University, Shahid Beheshti University of Medical Sciences

Language: English

Topic: Immune Cell Function and Interaction

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129007792

FWCI: 4.6

Cites:

Cited by: 2

Related to: